Effects of a Human Monoclonal Antibody and Cytokines on Human Malignant Glioma Cells
We have previously reported that the human monoclonal antibody (MAb) CLN-IgG, which is derived from human uterus cancer lymph node cells, binds strongly to malignant glioma cells and inhibits the tumor growth of gliomas subcutaneously transplanted into nude mice . However, it may be difficult for an antibody to reach all of the tumor cells because of unequal tumor antigen expression within a large tumor mass. Some cytokines have been reported to stimulate the expression of specific membrane surface antigens [2–5]. Accordingly, we performed this study to determine whether the antitumor effect of CLN-IgG on glioma cells was enhanced by cytokines.
KeywordsGlioma Cell Malignant Glioma Human Monoclonal Antibody Tumor Inoculation Malignant Glioma Cell
Unable to display preview. Download preview PDF.
- 1.Takahashi H, Nakazawa S, Herlyn D (1989) Experimental study of immunotherapy against malignant gliomas using monoclonal antibodies. Proc Jpn Cancer Assoc 48th Annu Meet, p 274Google Scholar
- 2.Gastl G, Marth C, Leiter E, Gattringer C, Mayer I, Daxenbichler G, Flener R, Huber C (1985) Effects of human recombinant α2 arg-interferon and γ-interferon on human breast cancer cell lines: Dissociation of antiproliferative activity and induction of HLA-DR antigen expression. Cancer Res 45: 2957–2961PubMedGoogle Scholar